» Articles » PMID: 39724463

Intestinal Oxygen Utilisation and Cellular Adaptation During Intestinal Ischaemia-reperfusion Injury

Overview
Journal Clin Transl Med
Publisher Wiley
Specialty General Medicine
Date 2024 Dec 26
PMID 39724463
Authors
Affiliations
Soon will be listed here.
Abstract

The gastrointestinal tract can be deranged by ailments including sepsis, trauma and haemorrhage. Ischaemic injury provokes a common constellation of microscopic and macroscopic changes that, together with the paradoxical exacerbation of cellular dysfunction and death following restoration of blood flow, are collectively known as ischaemia-reperfusion injury (IRI). Although much of the gastrointestinal tract is normally hypoxemic, intestinal IRI results when there is inadequate oxygen availability due to poor supply (pathological hypoxia) or abnormal tissue oxygen use and metabolism (dysoxia). Intestinal oxygen uptake usually remains constant over a wide range of blood flows and pressures, with cellular function being substantively compromised when ischaemia leads to a >50% decline in intestinal oxygen consumption. Restoration of perfusion and oxygenation provokes additional injury, resulting in mucosal damage and disruption of intestinal barrier function. The primary cellular mechanism for sensing hypoxia and for activating a cascade of cellular responses to mitigate the injury is a family of heterodimer proteins called hypoxia-inducible factors (HIFs). The HIF system is connected to numerous biochemical and immunologic pathways induced by IRI and the concentration of those proteins increases during hypoxia and dysoxia. Activation of the HIF system leads to augmented transcription of specific genes in various types of affected cells, but may also augment apoptotic and inflammatory processes, thus aggravating gut injury. KEY POINTS: During intestinal ischaemia, mitochondrial oxygen uptake is reduced when cellular oxygen partial pressure decreases to below the threshold required to maintain normal oxidative metabolism. Upon reperfusion, intestinal hypoxia may persist because microcirculatory flow remains impaired and/or because available oxygen is consumed by enzymes, intestinal cells and neutrophils.

References
1.
Birchenough G, Johansson M, Gustafsson J, Bergstrom J, Hansson G . New developments in goblet cell mucus secretion and function. Mucosal Immunol. 2015; 8(4):712-9. PMC: 4631840. DOI: 10.1038/mi.2015.32. View

2.
Derikx J, Matthijsen R, de Bruine A, van Bijnen A, Heineman E, M van Dam R . Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One. 2008; 3(10):e3428. PMC: 2561292. DOI: 10.1371/journal.pone.0003428. View

3.
Mecklenburgh K, Walmsley S, Cowburn A, Wiesener M, Reed B, Upton P . Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis. Blood. 2002; 100(8):3008-16. DOI: 10.1182/blood-2002-02-0454. View

4.
Megison S, Horton J, Chao H, Walker P . A new model for intestinal ischemia in the rat. J Surg Res. 1990; 49(2):168-73. DOI: 10.1016/0022-4804(90)90257-3. View

5.
Grasberger H, Gao J, Nagao-Kitamoto H, Kitamoto S, Zhang M, Kamada N . Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse Intestine. Gastroenterology. 2015; 149(7):1849-59. PMC: 4663159. DOI: 10.1053/j.gastro.2015.07.062. View